Clinical trial
NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC
NCT03169777 is registered in ClinicalTrials.gov with ImmunityBio, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC
- Lead sponsor
- ImmunityBio, Inc.
- Phase
- Phase 1/2
- Overall status
- Withdrawn
- Start date
- August 31, 2018
- Completion date
- December 28, 2021
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer